ArticleThe Journal of clinical investigation2022
Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicity.
Zhenhua Ren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
69 papers cite itlatest 60 shown
this paperpooled ittrialcites it